pharma · MAC Lung Disease · Mycobacterium Abscessus Infection · ANTX
AN2 Therapeutics
AN2 Therapeutics patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Menlo Park, USA HQ
2019 Founded
35 Employees
Public company Type
ANTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Menlo Park, USA
- Founded
- 2019
- Employees
- 35
- Programs
- 6
- Drugs
- 2
- Patents
- 0
AN2 Therapeutics patents
0 pharmaceutical patents indexed for AN2 Therapeutics. 0 expire within 24 months.
AN2 Therapeutics has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does AN2 Therapeutics have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do AN2 Therapeutics patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.